Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Who loses in biopharma as Treasury moves to block tax inversions?
Who loses in biopharma as Treasury moves to block tax inversions?
Who loses in biopharma as Treasury moves to block tax inversions?
Submitted by
admin
on September 23, 2014 - 8:00am
Source:
Fierce Biotech
News Tags:
tax inversions
Pfizer
Shire
AstraZeneca
AbbVie
Salix
Headline:
Who loses in biopharma as Treasury moves to block tax inversions?
Do Not Allow Advertisers to Use My Personal information
